Rubric Capital Management LP – Underwriting Agreements Watch

from DFAN14A 3 pages A Vote for Incumbent Directors David Habiger and Darcy Antonellis Is a Vote for Continued Underperformance

from DFAN14A 4 pages Do Not Be Fooled by Xperi’s Recent Attempts to Present a Falsified Version of Its Share Performance and Dilution to Stockholders. the Facts Are the Facts: Since the Spin-Off in 2022, Xperi Has Generated a Tsr of Nearly -34% While Stock-Based Compensation Has Increased Dramatically, Further Siphoning the Company From Investors.1

from SC 13D/A 19 pages Cooperation Agreement

from SC 13D/A 4 pages Ordinary Resolutions: 1. “That Dr. Peter Fellner, Dr. Anders Ekblom, Dr. Deepika Pakianathan and Mr. Michael Wyzga Be Removed From Office as Directors of the Company With Immediate Effect.” 2. “That Dr. Annalisa Jenkins Be Appointed as Director of the Company With Immediate Effect.” 3. “That Dr. Daniel Shames Be Appointed as Director of the Company With Immediate Effect.” 4. “That Mr. Marc Yoskowitz Be Appointed as Director of the Company With Immediate Effect.” 5. “That Mr. Justin Roberts Be Appointed as Director of the Company With Immediate Effect.”

from SC 13D/A 4 pages Ordinary Resolutions: 1. “That Dr. Peter Fellner, Dr. Anders Ekblom, Dr. Deepika Pakianathan, and Mr. Michael Wyzga Be Removed From Office as Directors of the Company With Immediate Effect” 2. “That Dr. Annalisa Jenkins, Dr. Daniel Shames, Mr. Marc Yoskowitz, and Mr. Justin Roberts Be Appointed as Directors of the Company With Immediate Effect”